iShares Core S&P 500 ETF vs Philip Morris International Inc. — how do they compare? iShares Core S&P 500 ETF trades at $779.92 (market cap $899.63B), while Philip Morris International Inc. trades at $199.75 (market cap $300.33B). The key difference: iShares Core S&P 500 ETF is far larger — about 3× Philip Morris International Inc.'s market cap, and Philip Morris International Inc. pays a 3.32% dividend while iShares Core S&P 500 ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core S&P 500 ETF for 46 Days and Philip Morris International Inc. for 85 Days on average.
| IVV | PM | |
|---|---|---|
Market Cap | $899.63B | $300.33B |
Volume | 3,643,926 | 3,935,700 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $782.58 | $200.50 |
52-Week Low | $634.93 | $144.33 |
Typical Hold Time | 46 Days | 85 Days |
Enterprise Value | — | $343.44B |
Dividend Yield | — | 3.32% |
Signals from Pluang's Aura AI — not financial advice
IVV, tracking the S&P 500, trades at $780.60, down 0.25% on the day. Technical indicators show a bullish trend with moving averages strongly positive, though RSI suggests potential overbought conditions near-term. The ETF remains a core holding for broad US equity exposure, with recent news highlighting strong corporate earnings growth expectations of 35% for 2026. Market sentiment is mixed as valuations attract scrutiny despite index strength.
Outlook remains constructive given the S&P 500's earnings momentum and historical seasonal trends favoring year-end rallies. Key risks include potential profit growth deceleration to 15% in 2027 and concentration in top holdings. The ETF offers diversified exposure to large-cap US equities, with the current level near pivot point support providing a strategic entry zone for long-term investors.
Philip Morris International (PM) trades at $200.5, up 5.3% over 24 hours, with a bullish technical signal and strong earnings beats in Q1 and Q2 2026. The company shows robust fundamentals with 2025 revenue of $40.65B and net income of $11.35B, supported by a 67.48% gross margin. Recent news highlights expansion of smoke-free products like ZYN and IQOS, now over 40% of revenue, driving growth amid industry shifts.
Outlook is positive with analyst consensus at Buy (68%) and a $212.17 price target, though elevated P/E of 26.46 and regulatory risks in tobacco remain concerns. Earnings growth and smoke-free product adoption are key catalysts, but investors should monitor debt levels and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →